Clinical Trial Update: A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating NW Low-Glu® for efficacy and safety in adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NW Low-Glu®

Snippet

Sponsor: Natural Wellness Egypt | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: UNKNOWN